Skip to main content

Table 2 Serum levels of ANCA and ASCA in UC patients with different disease status

From: Assessment of clinical activity and severity using serum ANCA and ASCA antibodies in patients with ulcerative colitis

Patients groupsNANCA-IgGASCA-IgAASCA-IgG
UC mild494.65 ± 2.813.36 ± 13.23.18 ± 5.02
UC moderate4014.70 ± 18.4c0.83 ± 2.004.47 ± 7.11
UC severe1664.00 ± 52.1a,b1.15 ± 3.042.86 ± 6.01
  1. Antibody levels are U/mL (mean ± SD)
  2. aComparison between UC severe group and UC moderate group (p < 0.01)
  3. bComparison between UC severe group and UC mild group (p < 0.01)
  4. cComparison between UC moderate group and UC mild group (p < 0.05)